Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. 10x Genomics Inc shares valued at $128,881 were sold by Saxonov Serge on Aug 22 ’25. At $13.79 per share, Saxonov Serge sold 9,348 shares. The insider’s holdings dropped to 945,892 shares worth approximately $13.51 million following the completion of this transaction.
Also, Taich Adam sold 22,315 shares, netting a total of over 307,657 in proceeds. Following the sale of shares at $13.79 each, the insider now holds 309,273 shares.
Before that, Hindson Benjamin J. had sold 7,486 shares from its account. In a trade valued at $103,209, the insider traded 10x Genomics Inc shares for $13.79 each. Upon closing the transaction, the insider’s holdings decreased to 7,486 shares, worth approximately $6.3 million.
As published in a research note from Leerink Partners on February 13, 2025, 10x Genomics Inc [TXG] has been rated down from an Outperform to a Market perform and the price target has been revised to $12 from $25. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in early September. As of July 22, 2024, Jefferies has increased its “Hold” rating to a “Buy” for TXG. Earlier on July 18, 2024, JP Morgan downgraded its rating. Their new recommendation was “a Neutral” for TXG stock which previously was a “an Overweight”.
Analyzing TXG Stock Performance
On last trading session, 10x Genomics Inc [NASDAQ: TXG] rose 1.85% to $14.28. The stock’s lowest price that day was $14.015, but it reached a high of $14.57 in the same session. During the last five days, there has been a surge of approximately 9.01%. Over the course of the year, 10x Genomics Inc shares have dropped approximately -37.37%. Shares of the company reached a 52-week high of $17.25 on 01/13/25 and a 52-week low of $6.78 on 04/07/25.
Support And Resistance Levels for 10x Genomics Inc (TXG)
According to the 24-hour chart, there is a support level at 14.00, which, if violated, would cause prices to drop to 13.73. In the upper region, resistance lies at 14.56. The next price resistance is at 14.85. RSI (Relative Strength Index) is 61.37 on the 14-day chart, showing neutral technical sentiment.
Is 10x Genomics Inc subject to short interest?
Stocks of 10x Genomics Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.62 million shares to 13.64 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 14.26 million shares. A decline of -4.54% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.01 of the overall float, the days-to-cover ratio (short ratio) decline to 4.01.
Which companies own the most shares of 10x Genomics Inc (TXG)?
In terms of 10x Genomics Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, down nearly -0.14% from the previous closing price of $14.02. Analysts anticipate 10x Genomics Inc stock to reach 16 by 2025, with the lowest price target being 13. In spite of this, 8 analysts ranked 10x Genomics Inc stock as Hold at the end of 2025. On July 10, 2024, Deutsche Bank assigned a price target of “a Hold” to the stock and downgraded coverage with a $25.
